Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy

<p><strong>Background:</strong> Pseudonormal T waves may be detected on stress electrocardiograms (ECGs) in hypertrophic cardiomyopathy (HCM). Either myocardial ischaemia or purely exercise-induced changes have been hypothesised to contribute to this phenomenon, but the pr...

Descripció completa

Dades bibliogràfiques
Autors principals:	Coleman, J, Doste, R, Beltrami, M, Olivotto, I, Raman, B, Bueno-Orovio, A
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2023

Ítems similars

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
per: Coleman, JA, et al.
Publicat: (2024)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
per: Coleman, JA, et al.
Publicat: (2023)

Pharmacological management of hypertrophic cardiomyopathy: From bench to bedside
per: Palandri, C, et al.
Publicat: (2022)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
per: Doste, R, et al.
Publicat: (2022)

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study
per: Coleman, JA, et al.
Publicat: (2024)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
per: Coleman, JA
Publicat: (2024)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
per: Coleman, J
Publicat: (2024)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
per: Coppini, R, et al.
Publicat: (2019)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
per: Margara, F, et al.
Publicat: (2022)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
per: Chow, J, et al.
Publicat: (2024)

Computational detection of electrophysiological abnormalities in hypertrophic cardiomyopathy for risk stratification
per: Lyon, A
Publicat: (2017)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
per: Passini, E, et al.
Publicat: (2015)

Insights into mechanisms and clinical implications of myocardial fibrosis and its progression in hypertrophic cardiomyopathy
per: Raman, B
Publicat: (2019)

Sudden death in hypertrophic cardiomyopathy.
per: Watkins, H
Publicat: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
per: Ashrafian, H, et al.
Publicat: (2001)

The genetic architecture of hypertrophic cardiomyopathy
per: Harper, AR
Publicat: (2020)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
per: Raman, B, et al.
Publicat: (2018)

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers
per: Lyon, A, et al.
Publicat: (2018)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
per: Hudsmith, L, et al.
Publicat: (2006)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
per: Lyon, A, et al.
Publicat: (2019)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
per: Dass, S
Publicat: (2012)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
per: Ashrafian, H, et al.
Publicat: (2005)

Linked genetic modifiers in hypertrophic cardiomyopathy
per: Ektisham, J, et al.
Publicat: (2004)

The genetics of hypertrophic cardiomyopathy: Teare redux.
per: Watkins, H, et al.
Publicat: (2008)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
per: Kramer, CM, et al.
Publicat: (2018)

Hypertrophic cardiomyopathy: from molecular and genetic mechanisms to clinical management
per: Watkins, H
Publicat: (2001)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
per: Lyon, A, et al.
Publicat: (2018)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
per: Suttie, J, et al.
Publicat: (2011)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
per: Karamitsos, T, et al.
Publicat: (2013)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
per: Ariga, R, et al.
Publicat: (2019)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
per: Pal, N
Publicat: (2015)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
per: Wordsworth, S, et al.
Publicat: (2006)

Mouse Model of Familial Hypertrophic Cardiomyopathy with E99K ACTC Mutation Recapitulates Many Features of Hypertrophic Cardiomyopathy in Patients
per: Song, W, et al.
Publicat: (2008)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
per: Ariga, R, et al.
Publicat: (2018)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
per: Neubauer, S, et al.
Publicat: (2019)

Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
per: Toepfer, C, et al.
Publicat: (2019)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
per: Ashrafian, H, et al.
Publicat: (2003)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
per: Watkins, H
Publicat: (2003)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
per: Ashrafian, H, et al.
Publicat: (2011)

Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy.
per: Edwards, R, et al.
Publicat: (1970)